Chronic kidney disease trials in Sweden
18 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleImlifidase Prior to Kidney Transplant in Highly Sensitised Children
- Where
- Huddinge
- Age
- 1 year to 17 years
- People
- 10 worldwide
- Run by
- Hansa Biopharma AB
See details and how to joinNCT05753930 · EU 2022-500230-28-00 - Phase 3Taking peopleA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Where
- Danderyd, Huddinge, Karlstad, Linkoping, Uppsala, Vaxjo
- Age
- 18 years and over
- People
- 5,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00 - Phase 4Taking peopleCKD-bioMatch: A biomarker-targeted clinical trial to optimize treatment for patients with chronic kidney disease
- Where
- Malmö
- Age
- 18 years and over
- People
- 115 worldwide
- Run by
- Steno Diabetes Center Copenhagen
See details and how to join2023-507449-27-01 · EU 2023-507449-27-01 - Phase 3Taking peopleA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- Where
- Huddinge
- Age
- 18 years to 100 years
- People
- 540 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00 - No phaseTaking peopleSafety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited Potassium Content in Patients With Chronic Kidney Disease: A Pilot Study
- Where
- Huddinge
- Age
- 20 years to 85 years
- People
- 30
- Run by
- Karolinska Institutet
See details and how to joinNCT07494266 - Phase 1/2Taking peopleStudy of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
- Where
- Stockholm
- Age
- 18 years and over
- People
- 75 worldwide
- Run by
- Oncorena AB
See details and how to joinNCT05287945 - Phase 3Taking peopleA Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
- Where
- Huddinge, Lund, Uppsala
- Age
- 1 year to 18 years
- People
- 100 worldwide
- Run by
- Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00 - Phase 2/3Taking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Huddinge, Stockholm, Uppsala
- Age
- 18 years and over
- People
- 3,110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - Phase 3Taking peopleA Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- Where
- Danderyd, Falun, Gothenburg, Huddinge, Karlstad, Linkoping, Lund, Orebro, Uppsala, Vaxjo
- Age
- 18 years and over
- People
- 7,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00 - No phaseTaking peopleUppsala Self-Screening of Cardiovascular Health
- Where
- Uppsala
- Age
- 50 years to 75 years
- People
- 45,000
- Run by
- Johan Sundström
See details and how to joinNCT07614659 - Phase 3Taking peopleSACK
- Where
- Boras, Danderyd, Eksjo, Eskilstuna, Falun, Gavle, Gothenburg, Halmstad, Huddinge, Jonkoping, Kalmar, Karlskrona, Karlstad, Kristianstad, Linkoping, Lulea, Lund, Malmo, Norrkoping, Nykoping, Orebro, Östersund, Skovde, Sundsvall, Trollhattan, Umea, Umeå, Uppsala, Varberg, Västerås, Vaxjo, Ystad
- Age
- 18 years and over
- People
- 1,281 worldwide
- Run by
- Karolinska University Hospital
See details and how to join2022-501600-10-00 · EU 2022-501600-10-00 - No phaseTaking peopleInternational (Pediatric) Peritoneal Biobank
- Where
- Stockholm
- Age
- 1 day to 90 years
- People
- 500 worldwide
- Run by
- Heidelberg University
See details and how to joinNCT01893710 - Phase 3Taking peopleEfficacy and Safety of XyloCore Peritoneal Dialysis Solution.
- Where
- Halmstad, Stockholm
- Age
- 18 years and over
- People
- 170 worldwide
- Run by
- Iperboreal Pharma Srl
See details and how to joinNCT03994471 - Phase 2Taking peopleSwedish Cardiac And Renal Failure Study-1
- Where
- Danderyd
- Age
- 18 years and over
- People
- 40
- Run by
- Karolinska Institutet
See details and how to joinNCT07029503 · EU 2025-520550-11-00 - Phase 4Taking peopleA Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease
- Where
- Malmö
- Age
- 18 years to 75 years
- People
- 125 worldwide
- Run by
- Peter Rossing
See details and how to joinNCT07239570 - No phaseTaking peopleThe Effect of the Nutraceutical (-)- Epicatechin on Myosteatosis in Patients With Advanced CKD
- Where
- Huddinge
- Age
- 60 years and over
- People
- 10
- Run by
- Karolinska Institutet
See details and how to joinNCT06631820 - Phase 3Taking peopleStroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
- Where
- Borås, Falun, Gothenburg, Jönköping, Kalix, Kalmar, Karlshamn, Karlstad, Linköping, Lund, Malmö, Mora, Norrköping, Örebro, Östersund, Skellefteå, Skövde, Stockholm, Sundsvall, Umeå, Uppsala, Varberg, Västerås
- Age
- 18 years and over
- People
- 1,400 worldwide
- Run by
- Region Stockholm
See details and how to joinNCT05679024 - No phaseTaking peoplePrognostic Imaging Biomarkers for Diabetic Kidney Disease
- Where
- Malmö
- Age
- 18 years to 80 years
- People
- 500 worldwide
- Run by
- University of Leeds
See details and how to joinNCT03716401